Galectin Therapeutics raises $3M in private placement Galectin announced completion of a $3M private placement of 500,000 shares of unregistered common stock to a single investor. Previously, the Company announced it had $5.1 million of non-restricted cash and cash equivalents available at June 30, 2013 and subsequently received $2.4M from the exercise of warrants. With the addition of the $3M in proceeds from the current transaction, the Company believes it has sufficient funding for operations and planned research and development through the second quarter of 2014.
News For GALT From The Last 14 Days
Check below for free stories on GALT the last two weeks.